A detailed history of Amalgamated Bank transactions in Amgen Inc stock. As of the latest transaction made, Amalgamated Bank holds 113,663 shares of AMGN stock, worth $35.9 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
113,663
Previous 114,204 0.47%
Holding current value
$35.9 Million
Previous $32.5 Million 9.37%
% of portfolio
0.3%
Previous 0.28%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$262.75 - $319.31 $142,147 - $172,746
-541 Reduced 0.47%
113,663 $35.5 Million
Q1 2024

Apr 23, 2024

SELL
$268.87 - $324.56 $4.62 Million - $5.57 Million
-17,172 Reduced 13.07%
114,204 $32.5 Million
Q4 2023

Feb 06, 2024

SELL
$255.7 - $288.46 $1.7 Million - $1.92 Million
-6,666 Reduced 4.83%
131,376 $37.8 Million
Q3 2023

Nov 08, 2023

SELL
$218.65 - $271.46 $681,750 - $846,412
-3,118 Reduced 2.21%
138,042 $37.1 Million
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $3.39 Million - $4 Million
-15,806 Reduced 10.07%
141,160 $31.3 Million
Q1 2023

May 02, 2023

BUY
$225.79 - $275.2 $2.78 Million - $3.39 Million
12,314 Added 8.51%
156,966 $37.9 Million
Q4 2022

Feb 10, 2023

SELL
$229.03 - $291.01 $703,809 - $894,273
-3,073 Reduced 2.08%
144,652 $38 Million
Q3 2022

Nov 09, 2022

BUY
$224.46 - $253.15 $1.49 Million - $1.68 Million
6,627 Added 4.7%
147,725 $33.3 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $3.67 Million - $4.08 Million
-15,909 Reduced 10.13%
141,098 $34.3 Million
Q1 2022

Jun 30, 2022

BUY
$219.27 - $242.57 $690,700 - $764,095
3,150 Added 2.05%
157,007 $38 Million
Q4 2021

Feb 15, 2022

BUY
$198.88 - $227.6 $4.45 Million - $5.09 Million
22,364 Added 17.01%
153,857 $34.6 Million
Q3 2021

Oct 29, 2021

SELL
$212.27 - $248.7 $1.65 Million - $1.93 Million
-7,773 Reduced 5.58%
131,493 $28 Million
Q2 2021

Aug 16, 2021

BUY
$233.58 - $259.14 $24.2 Million - $26.8 Million
103,478 Added 289.14%
139,266 $33.9 Million
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $388,786 - $453,067
-1,752 Reduced 4.67%
35,788 $8.9 Million
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $122,038 - $145,325
-564 Reduced 1.48%
37,540 $8.63 Million
Q3 2020

Oct 30, 2020

SELL
$234.65 - $260.95 $281,110 - $312,618
-1,198 Reduced 3.05%
38,104 $9.69 Million
Q2 2020

Aug 10, 2020

SELL
$197.81 - $242.74 $11.6 Million - $14.2 Million
-58,552 Reduced 59.84%
39,302 $9.27 Million
Q1 2020

May 13, 2020

SELL
$182.24 - $241.7 $858,714 - $1.14 Million
-4,712 Reduced 4.59%
97,854 $19.8 Million
Q4 2019

Feb 13, 2020

BUY
$189.21 - $243.2 $579,928 - $745,408
3,065 Added 3.08%
102,566 $24.7 Million
Q3 2019

Nov 13, 2019

BUY
$174.11 - $208.62 $3.13 Million - $3.75 Million
17,963 Added 22.03%
99,501 $19.3 Million
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $2.14 Million - $2.5 Million
-12,817 Reduced 13.58%
81,538 $15 Million
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $152,292 - $171,666
842 Added 0.9%
94,355 $17.9 Million
Q4 2018

Feb 15, 2019

SELL
$178.4 - $208.25 $658,474 - $768,650
-3,691 Reduced 3.8%
93,513 $18.2 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $963,878 - $1.09 Million
-5,202 Reduced 5.08%
97,204 $20.1 Million
Q2 2018

Jul 18, 2018

BUY
$166.05 - $186.51 $1.47 Million - $1.65 Million
8,861 Added 9.47%
102,406 $18.9 Million
Q1 2018

May 22, 2018

SELL
$169.43 - $198.0 $60,994 - $71,280
-360 Reduced 0.38%
93,545 $15.9 Million
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $1.4 Million - $1.56 Million
8,266 Added 9.65%
93,905 $16.3 Million
Q3 2017

Nov 09, 2017

BUY
$167.29 - $191.0 $14.3 Million - $16.4 Million
85,639
85,639 $16 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.